• No results found

anti-angiogenic therapy

Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme

Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme

... mice. However, survival benefit by Bevacizumab was significantly decreased by in vivo serial transplantations of Bevacizumab-treated tumors. Indeed, the development of Bevacizumab-resistance over time may represent the ...

13

Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.

Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.

... to anti-angiogenic therapy in preclinical lung metastasis ...with anti-angiogenic therapy, we have not been able to examine if there is an association between vessel co-option ...

58

Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy

Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy

... Tumour growth and neo-vessel growth are coupled by the chemical microenvironment including oxygen, VEGF, ECM and MDE, which are described by continuous partial differential equations. At the same time, haemodynamic ...

16

Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics

Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics

... of anti- and angiogenic factors is well ...of angiogenic stimulators ...of angiogenic inhibitors ...of angiogenic factors may lead to reducing the IFP and enhancing tumor oxygenation, ...

17

Anti-angiogenic therapy for cancer: Current progress, unresolved questions and future directions

Anti-angiogenic therapy for cancer: Current progress, unresolved questions and future directions

... effective anti- angiogenic therapy for most tumour ...VEGF-targeted therapy and the unresolved questions that exist in the field: including its use in dif- ferent disease stages (metastatic, ...

24

Inhibition of endoplasmic reticulum chaperone protein glucose- regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway

Inhibition of endoplasmic reticulum chaperone protein glucose- regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway

... several anti-tumor ...during anti-angiogenic therapy remains ...during anti-angiogenic therapy and the potential role of GRP78 in combined therapy in renal cell ...

13

Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer

Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer

... in anti-tumor ...the therapy of colorectal cancer ...of anti-angiogenic therapy was resulted from their ability to upregulate CD47 expression in tumor microenvironment conferring NSCLC ...

11

Targeting hypoxic cancer stem cells (CSCs) with Doxycycline :
implications for optimizing anti angiogenic therapy

Targeting hypoxic cancer stem cells (CSCs) with Doxycycline : implications for optimizing anti angiogenic therapy

... of anti-angiogenic agents could be improved by using combination strategies aimed at inhibiting both cancer- and cancer stem-like ...combination therapy would effectively block both: i) blood vessel ...

18

Recent Advances in Anti-Angiogenic Therapy of Cancer

Recent Advances in Anti-Angiogenic Therapy of Cancer

... of anti-angiogenic drugs from the perspective of impacting survival have left much to desire, endorsing a need for developing more effective therapeutic regimens ...combining anti-angiogenic ...

13

Role of Anti Angiogenic Therapy in Prevention of Recurrence in Hormonal Positive Breast Cancer: A Secondary Prevention Strategy and Method of Therapy

Role of Anti Angiogenic Therapy in Prevention of Recurrence in Hormonal Positive Breast Cancer: A Secondary Prevention Strategy and Method of Therapy

... Existing literature supports the role of signaling protein vascular endothelial growth factor (VEGF) in tumor growth and metastasis and furthers its in- volvement in recurrence. In both experimental and clinical studies, ...

7

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy

... interferon therapy and the latter in the anti-VEGF therapy ...ICI therapy in mRCC and the availability of multiple other systemic therapy choices, there is an unmet need for updates to ...

8

Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.

Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.

... HT29 cells stably transfected with a control non-targeting shRNA (control shRNA) (a) or an ARPC3-targeted shRNA (shARPC3-3) (b) were prepared for FFPE sections and then stained using an anti-ARPC3 antibody ...

83

Deciphering the anti angiogenic effect of endostatin/cyclophosphamide to normalize tumor micrangium through notch signaling pathway in colon cancer

Deciphering the anti angiogenic effect of endostatin/cyclophosphamide to normalize tumor micrangium through notch signaling pathway in colon cancer

... progression of cancer and higher the microvessel count, greater the metastatic rate of cancer [24 – 27]. Vascular endothelial growth factor (VEGF) is a largely studied angiogenesis regulating growth factor that is ...

8

Future options of anti-angiogenic cancer therapy

Future options of anti-angiogenic cancer therapy

... combination therapy can be explained by a decrease of chemotherapeutic toxicity ...[62]. Anti-VEGF treatment ablates VEGF-induced anemia and thus increases tolerance of ...of anti-angiogenic ...

9

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab

... receiving anti-angiogenic ...to anti-angiogenic therapy with ...of anti- angiogenesis therapy was tested by measuring tumour uptake of 111 In-bevacizumab in comparison to ...

9

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer

... and Anti-Angiogenic Therapy in Platinum- Sensitive Recurrent Disease]) that led to European Medicines Agency approval of bevacizumab in platinum-sensitive first relapse and discuss the best use of ...

8

Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging

<p>Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging</p>

... novel anti-angiogenic therapies, which act by reducing neo-angiogenesis, and improving patient ...with anti-angiogenic therapy is effective monitoring of treatment response, which ...

13

Comparison of anti angiogenic properties of pristine carbon nanoparticles

Comparison of anti angiogenic properties of pristine carbon nanoparticles

... their angiogenic activities using the in ovo chick embryo chorioallantoic membrane ...greatest anti-angiogenic ...in anti-angiogenic tumour ...

8

Briefly about Anticancer Properties of Statins

Briefly about Anticancer Properties of Statins

... (Cysteine-rich angiogenic inducer 6) expression resulting in suppressed osteosarcoma cell invasion and altered epithelial-to-mesenchymal-transition-related protein expression ...

5

The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia

The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia

... of angiogenic factors may lead to new prognostic and therapeutic points in management of ...some anti-angiogenic factors as potential candidate to be used as early predictors for ...to ...

12

Show all 10000 documents...

Related subjects